[go: up one dir, main page]

RU2009142106A - Gliatilin and transcranial micropolarization in the treatment of children with autistic disorders - Google Patents

Gliatilin and transcranial micropolarization in the treatment of children with autistic disorders Download PDF

Info

Publication number
RU2009142106A
RU2009142106A RU2009142106/15A RU2009142106A RU2009142106A RU 2009142106 A RU2009142106 A RU 2009142106A RU 2009142106/15 A RU2009142106/15 A RU 2009142106/15A RU 2009142106 A RU2009142106 A RU 2009142106A RU 2009142106 A RU2009142106 A RU 2009142106A
Authority
RU
Russia
Prior art keywords
gliatilin
children
treatment
autistic disorders
micropolarization
Prior art date
Application number
RU2009142106/15A
Other languages
Russian (ru)
Other versions
RU2429831C2 (en
Inventor
Татьяна Евгеньевна Старовойтова (RU)
Татьяна Евгеньевна Старовойтова
Анастасия Вячеславовна Власенко (RU)
Анастасия Вячеславовна Власенко
Владимир Валентинович Долгих (RU)
Владимир Валентинович Долгих
Ванда Иосифовна Михнович (RU)
Ванда Иосифовна Михнович
Людмила Георгиевна Долгих (RU)
Людмила Георгиевна Долгих
Ольга Николаевна Протопопова (RU)
Ольга Николаевна Протопопова
Татьяна Анатольевна Тетерина (RU)
Татьяна Анатольевна Тетерина
Татьяна Альбертовна Белогорова (RU)
Татьяна Альбертовна Белогорова
Original Assignee
Учреждение Российской академии медицинских наук Научный центр проблем здоровья семьи и репродукции человека Сибирского отделения РАМ
Учреждение Российской академии медицинских наук Научный центр проблем здоровья семьи и репродукции человека Сибирского отделения РАМН
Общество с ограниченной ответственностью "Клиника института педиатрии" (RU)
Общество с ограниченной ответственностью "Клиника Института Педиатрии"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Учреждение Российской академии медицинских наук Научный центр проблем здоровья семьи и репродукции человека Сибирского отделения РАМ, Учреждение Российской академии медицинских наук Научный центр проблем здоровья семьи и репродукции человека Сибирского отделения РАМН, Общество с ограниченной ответственностью "Клиника института педиатрии" (RU), Общество с ограниченной ответственностью "Клиника Института Педиатрии" filed Critical Учреждение Российской академии медицинских наук Научный центр проблем здоровья семьи и репродукции человека Сибирского отделения РАМ
Priority to RU2009142106/15A priority Critical patent/RU2429831C2/en
Publication of RU2009142106A publication Critical patent/RU2009142106A/en
Application granted granted Critical
Publication of RU2429831C2 publication Critical patent/RU2429831C2/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Применение глиатилина в качестве лекарственного средства и транскраниальной микрополяризации в составе комплексного лечения детей с аутистическими расстройствами на фоне стандартных схем лечения. The use of gliatilin as a medicine and transcranial micropolarization as part of the complex treatment of children with autistic disorders against the background of standard treatment regimens.

Claims (1)

Применение глиатилина в качестве лекарственного средства и транскраниальной микрополяризации в составе комплексного лечения детей с аутистическими расстройствами на фоне стандартных схем лечения. The use of gliatilin as a medicine and transcranial micropolarization as part of the complex treatment of children with autistic disorders against the background of standard treatment regimens.
RU2009142106/15A 2009-11-16 2009-11-16 Application of gliatilin and transcranial micropolarisation in treatment of children with autistic disturbances RU2429831C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2009142106/15A RU2429831C2 (en) 2009-11-16 2009-11-16 Application of gliatilin and transcranial micropolarisation in treatment of children with autistic disturbances

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2009142106/15A RU2429831C2 (en) 2009-11-16 2009-11-16 Application of gliatilin and transcranial micropolarisation in treatment of children with autistic disturbances

Publications (2)

Publication Number Publication Date
RU2009142106A true RU2009142106A (en) 2011-05-27
RU2429831C2 RU2429831C2 (en) 2011-09-27

Family

ID=44734318

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2009142106/15A RU2429831C2 (en) 2009-11-16 2009-11-16 Application of gliatilin and transcranial micropolarisation in treatment of children with autistic disturbances

Country Status (1)

Country Link
RU (1) RU2429831C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2666598C1 (en) * 2017-07-14 2018-09-11 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фармакологии имени В.В. Закусова" Agent for correcting autism spectrum disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2601132C (en) * 1998-04-14 2011-11-08 The General Hospital Corporation Use of n-methylglycine and pharmaceutical compositions comprising n-methylglycine for treating neuropsychiatric disorders
RU2248227C1 (en) * 2004-06-16 2005-03-20 Кожушко Надежда Юрьевна Method for treating children for psychical development disorders

Also Published As

Publication number Publication date
RU2429831C2 (en) 2011-09-27

Similar Documents

Publication Publication Date Title
HUE043175T2 (en) Synthetic triterpenoids and their use in the treatment of disease
CA2900335C (en) Synthetic analogs of epipolythiodioxopiperazines and uses thereof
CL2010001159A1 (en) Compounds derived from 3,8-diazabicyclo [2.4.0] octane and 3,6-diazabicyclo [3.2.0] heptane disubstituted, orexin receptor modulators; pharmaceutical composition; Useful in the treatment of sleep disorders, metabolic disorders, among others.
IL227990A0 (en) Use of 3-(5-amino-2-methyl-4-oxoquinlosin-3-(4h)-yl)piperidine-2,6-dinone in the treatment of diseases related to the immune system and inflammatory diseases
EA201170465A1 (en) METHODS OF TREATMENT OF PROGRESSIVE MULTIPLE SCLEROSIS
EA201500314A1 (en) DOSAGE FORMS OF ENZALUTAMIDE
CR20150232A (en) IMIDAZO [1,2-A] PIRIDINCARBOXAMIDS AMINOSUSTITUIDAS AND ITS USE
WO2014176128A3 (en) Compositions and methods for the therapy and diagnosis of influenza
HRP20192130T1 (en) COMBINATION THERAPY FOR THE TREATMENT OF PATIENTS WITH NEUROLOGICAL DISORDERS AND STROKE
CA2871774C (en) Use of n-acetylcysteine amide in the treatment of disease and injury
CO7160080A2 (en) Lipid compositions of racecadot
CA3010708A1 (en) Methods of administering hepcidin
UY33219A (en) CYCLIC CETOENOLS FOR THERAPIES
IT1398378B1 (en) CYTICOLINE FOR THE TREATMENT OF GLAUCOMA AND OCULAR HYPERTENSION.
HK1206984A1 (en) Combination therapy of anti-mif antibodies and glucocorticoids
EA201070195A1 (en) DERIVATIVES 1,2,3,4-TETRAGIDROPYRROLO [1,2-A] PIRAZIN-6-CARBOXAMIDES AND 2,3,4,5-TETRAHYDROPYRROLO [1,2-a] [1,4] -DIAZEPIN-7-CARBOXAMIDES , THEIR RECEIVING AND THEIR APPLICATION IN THERAPY
UY29777A1 (en) USE OF AGOMELATINE FOR THE OBTAINING OF MEDICINES FOR THE TREATMENT OF SOIL DISORDERS IN PATIENTS WITH DEPRESSION.
EA201490562A1 (en) METHODS OF TREATMENT-ASSOCIATED TOUCH-MOTOR INSUFFICIENCY WITH THE USE OF AMINOPYRIDINES
UA108975C2 (en) APPLICATION OF THE Copolymer of Sodium Carboxymethylcellulose and Gosipol in Complex Therapy of Patients with Autistic Disorders and Cogniitis
WO2015168656A3 (en) Biological complexes and methods for using same
HK1206985A1 (en) Combination therapy of anti-mif antibodies and chemotherapeutics
RU2009142106A (en) Gliatilin and transcranial micropolarization in the treatment of children with autistic disorders
EA201390532A1 (en) COMPOSITIONS OF NS3 SULFAMIDE INHIBITORS CONTAINING VITAMIN E
GEP20156373B (en) Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease
EA201200865A1 (en) THERAPEUTIC APPLICATION OF PROTEIN CONJUGATS WITH POLYMER

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20141117